RADIATION FOR SCIENCE AND SOCIETY

KeywordsRadiopharmaceuticals

Molecular ImagingNuclear Medicine

TheranosticsNanomedicine

C2TN members: António Paulo1*, Célia Fernandes1, Cristina Oliveira1, Elisa Palma1 (FCT), FernandaMarques1, Filipa Mendes1, Francisco Silva1 (C2TN contract), Joana F Guerreiro1,2 (C2TN contract), João DGCorreia1, Lurdes Gano1, Paula Campello1, Paula Raposinho1, Rita Melo1 (FCT)Students: Alice D´Onofrio1 (PhD), João Machado1 (PhD), Mihaela Cudalbeanu1 (PhD), Vera Ferreira1 (PhD),Adriana Cruz1 (MSc), Ana Amendoeira1 (MSc), Ana Inácio1,2 (MSc), Diogo Figueiredo1,2 (MSc), SofiaBatanete1 (MSc), Mariana David1 (Research fellow), Rúben Silva1 (Research fellow)

* Email of corresponding author: apaulo@ctn.tecnico.ulisboa.pt

Collaborations

RADIOPHARMACEUTICAL SCIENCES GROUP

Thematic Strand

Radiopharmaceutical Sciences and Health Physics

C2TN/IST acknowledges the financial supportunder the project UID/Multi/04349/2013

http://c2tn.tecnico.ulisboa.pt

Assiut University, Assiut, Egypt

University of Missouri, Columbia, Missouri, USA

IQSC-USP I Instituto de Química de São, Carlos, Universidade de São Paulo, São Carlos, Brasil

University of Cambridge, Cambridge, UK

CERN I European Laboratory for Particle Physics, Geneva, Switzerland

ICMAB I Instituto de Ciencia de Materiales de Barcelona- CSIC, Barcelona, Spain

iSm2 I Institut des Sciences Moléculaires de Marseille-CNRS, Marseille, France

POLATOM I National Centre for Nuclear Research, Otwock, Poland

TUM I Technische Universität München, Munich, Germany

Université de Sherbrooke, Sherbrooke, Canada

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Alessandria,Italy

Universitat Wien, Vienna, Austria

ULB I Université libre de Bruxelles, Brussels, Belgium

UGAL I "Dunarea de Jos“University of Galati, Galati, Romania

InfrastructuresLaboratories for Chemical and

Radiochemical SynthesisLaboratories for

Biological Studies

Chemical Synthesis

Solid Phase Peptide Synthesis

Synthesis of RadiocompoundsAnimal Studies

Biochemical Studies

Cell Studies

Acridine Orange Derivatives for DNA-Targeting

Indium(III) Complexes for Dual Targeting of Breast Cancer

Multifunctional Gold Nanoparticles for Targeted Cancer Theranostics

Design of HER2-Specific Virus-Like Particles for Image-Guided Drug Delivery

Main Achievements

MISSION AND OBJECTIVES: The Radiopharmaceutical Sciences Group develops fundamental and applied research activities on the development

and preclinical evaluation of radioactive tools for Molecular Imaging (PET, SPECT) and Targeted Radionuclide Therapy, in the Life Sciences and Health domain.

Highlights of national and international collaborations

RSG in Numbers

CICS I Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Covilhã

ICNAS I Instituto de Ciências Nucleares Aplicadas à Saúde, Universidade de Coimbra, Coimbra

FC I Fundação Champalimaud, Lisboa

FCT I Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica

i3S I Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto

FCUL, FFUL | Universidade de Lisboa, Lisboa

CNC | Centro de Neurociências e Biologia Celular, Universidade de Coimbra, Coimbra

Mount Sinai, NYC, USA

Utrech University, Utrech, Netherlands

IMM I Instituto de Medicina Molecular, Lisboa

Harvard Medical School, Boston, USA

Research group1 RS | Radiopharmaceutical Sciences Group2 RPS | Radiation Protection and Safety Group